A new target for cancer drug development

Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.

http://www.eurekalert.org/pub_releases/2013-06/hu-ant061713.php